ProPhase Labs, Inc.
Index- P/E16.75 EPS (ttm)0.69 Insider Own16.60% Shs Outstand15.49M Perf Week0.52%
Market Cap179.18M Forward P/E29.41 EPS next Y0.39 Insider Trans0.03% Shs Float12.54M Perf Month-15.74%
Income17.70M PEG- EPS next Q0.06 Inst Own11.60% Short Float2.22% Perf Quarter56.25%
Sales111.30M P/S1.61 EPS this Y270.00% Inst Trans7.47% Short Ratio1.46 Perf Half Y81.96%
Book/sh4.29 P/B2.69 EPS next Y-54.14% ROA7.40% Target Price11.33 Perf Year134.24%
Cash/sh1.89 P/C6.12 EPS next 5Y- ROE11.40% 52W Range4.38 - 15.25 Perf YTD75.11%
Dividend- P/FCF- EPS past 5Y28.10% ROI15.70% 52W High-24.20% Beta-0.36
Dividend %- Quick Ratio3.40 Sales past 5Y79.80% Gross Margin55.50% 52W Low163.76% ATR1.08
Employees129 Current Ratio3.70 Sales Q/Q210.50% Oper. Margin8.90% RSI (14)50.29 Volatility7.10% 10.51%
OptionableYes Debt/Eq0.12 EPS Q/Q1082.00% Profit Margin5.60% Rel Volume0.00 Prev Close11.56
ShortableYes LT Debt/Eq0.12 EarningsAug 11 BMO Payout0.00% Avg Volume190.62K Price11.56
Recom2.70 SMA205.87% SMA50-2.13% SMA20044.41% Volume0 Change0.00%
Dec-20-21Initiated H.C. Wainwright Buy $12
Oct-13-21Downgrade Dawson James Buy → Neutral
Jan-20-21Initiated Dawson James Buy $25
Aug-11-22 09:25AM  
Aug-04-22 08:33PM  
Aug-02-22 06:15PM  
Jul-28-22 03:24PM  
Jul-26-22 08:00AM  
Jul-21-22 06:00PM  
Jul-19-22 08:30AM  
Jul-18-22 07:38AM  
Jul-12-22 06:30AM  
Jul-11-22 06:25AM  
Jul-08-22 07:48AM  
Jul-04-22 09:40AM  
Jun-29-22 12:00PM  
Jun-28-22 08:30AM  
Jun-22-22 10:06AM  
Jun-13-22 09:40AM  
May-27-22 10:20AM  
May-26-22 10:01AM  
May-25-22 10:16AM  
May-24-22 12:00PM  
May-18-22 08:15AM  
May-16-22 01:20PM  
May-13-22 09:55AM  
May-12-22 07:45AM  
May-11-22 06:25PM  
May-10-22 08:15AM  
May-09-22 05:25PM  
May-06-22 04:30PM  
May-05-22 11:12AM  
May-03-22 06:36AM  
May-02-22 10:12AM  
Apr-27-22 09:00AM  
Apr-21-22 12:00PM  
Apr-19-22 07:02AM  
Apr-18-22 08:45AM  
Apr-14-22 10:38AM  
Apr-11-22 07:50AM  
Apr-06-22 12:36PM  
Apr-05-22 12:54PM  
Apr-01-22 08:00PM  
Mar-30-22 08:30AM  
Mar-24-22 08:15AM  
Feb-16-22 08:15AM  
Feb-08-22 09:26AM  
Feb-03-22 08:30AM  
Jan-28-22 10:07AM  
Jan-13-22 08:15AM  
Jan-05-22 08:30AM  
Dec-16-21 08:30AM  
Nov-23-21 04:15PM  
Nov-12-21 08:30AM  
Nov-10-21 08:30AM  
Nov-05-21 08:30AM  
Oct-13-21 08:30AM  
Oct-06-21 08:30AM  
Sep-22-21 08:30AM  
Sep-08-21 08:30AM  
Sep-07-21 08:30AM  
Aug-16-21 08:30AM  
Aug-13-21 08:11AM  
Aug-12-21 06:37AM  
Aug-11-21 08:30AM  
Aug-09-21 08:30AM  
Jul-12-21 08:30AM  
Jul-01-21 08:30AM  
Jun-28-21 08:30AM  
Jun-18-21 11:56AM  
Jun-10-21 08:30AM  
May-28-21 08:30AM  
May-14-21 02:36AM  
May-13-21 04:05PM  
May-06-21 08:30AM  
Apr-22-21 08:30AM  
Apr-15-21 08:01AM  
Mar-31-21 02:30PM  
Mar-30-21 05:10PM  
Mar-15-21 08:30AM  
Feb-17-21 07:06AM  
Feb-09-21 08:30AM  
Feb-01-21 08:30AM  
Jan-29-21 08:30AM  
Jan-21-21 04:30PM  
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. The company also provides contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; SARS-CoV-2 (COVID-19) and COVID-19 viral mutation polymerase chain reaction tests through saliva and nasal swab methods; and other respiratory pathogen panel molecular testing services, as well as personal genomics products and services. It serves national chain drug, internet-based, and various regional retailers. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Karkus Ted WilliamCEO & CHAIRMANAug 10Option Exercise0.60600,000360,0003,105,214Aug 10 09:23 PM
Karkus Ted WilliamCEO & CHAIRMANMay 23Option Exercise2.00450,000900,0002,783,471May 25 05:20 PM
Brady Monica L.Chief Accounting OfficerMay 23Option Exercise2.5239,25099,06546,678May 25 05:18 PM
Barr Jason MichaelDirectorMar 10Buy6.487504,86030,991Mar 16 07:17 PM